Transcatheter Approaches to Atrial Functional Mitral Regurgitation: How Far Have We Come?
Authors:
- 26 December 2024
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (1) , 28-40
Abstract
Functional mitral regurgitation (MR) is associated with increased cardiovascular morbidity and mortality and over the past decade, the diagnosis of atrial functional mitral regurgitation (aFMR) has been increasingly observed in the elderly, especially in those with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF). Annular enlargement, perturbations of annular contraction, and atriogenic leaflet tethering distinguish the pathophysiology of aFMR from the one of ventricular origin. However, no consensus provides recommendations regarding the differential diagnosis and the subsequent management of aFMR. The advent of transcatheter mitral valve repair has paved the way for various treatments including edge‐to‐edge repair (TEER), mitral annuloplasty, and replacement, with optimistic results on short‐medium‐term outcome provided by preliminary studies. In parallel, rhythm control of AF for paroxysmal and persistent types, should be pursued to induce reverse remodeling and restoring the normal leaflet coaptation. In this setting, catheter ablation aiming for electrical isolation of the pulmonary veins is the most widely recognized and effective strategy for maintaining sinus rhythm. Nevertheless, arrhythmia‐free survival is lower in patients with persistent and long‐term persistent AF, leading to the adoption of hybrid strategies combining transcatheter endocardial ablation and thoracoscopic epicardial surgical ablation. This review provides an update on the diagnosis and treatment of aFMR, focusing on available transcatheter approaches that can be performed in the catheterization lab and electrophysiology lab.Keywords
This publication has 96 references indexed in Scilit:
- Outcomes of transcatheter edge‐to‐edge repair for atrial functional mitral regurgitation: A meta‐analysis of observational studiesCatheterization and Cardiovascular Interventions, 2023
- Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical managementReviews in Endocrine and Metabolic Disorders, 2023
- Mitral valve edge‐to‐edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitationCatheterization and Cardiovascular Interventions, 2022
- Influence of Catheter Ablation for Atrial Fibrillation on Atrial and Ventricular Functional Mitral RegurgitationESC Heart Failure, 2022
- Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial FibrillationJAMA Cardiology, 2021
- Functional Mitral Regurgitation and Left Atrial Myopathy in Heart Failure with Preserved Ejection FractionEuropean Journal of Heart Failure, 2020
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial FibrillationJAMA, 2019
- One‐stop shop: Simultaneous direct mitral annuloplasty and percutaneous mitral edge‐to‐edge repair in a patient with severe mitral regurgitationCatheterization and Cardiovascular Interventions, 2018
- The mechanism of mitral regurgitation assessed by preprocedural echocardiography is associated with the outcome of catheter ablation in patients with paroxysmal atrial fibrillationJournal of Interventional Cardiac Electrophysiology, 2016
- Tissue Ablation with Irreversible ElectroporationAnnals of Biomedical Engineering, 2005